Stocks › HIMS
Hims & Hers Health, Inc.
HIMS·NYSE·
United States·USD
$14.60
-1.42 (-8.86%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HIMS
Hims & Hers Health, Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HIMSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HIMS by members of U.S. Congress · 5 on record · 2 in the last 12 months
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Tony WiedHouse · R · WI |
HIMSHims & Hers Health, Inc. · Stock |
Purchase $50,001 - $100,000 |
Mar 9, 2026 | Feb 3, 2026 | Filing ↗ |
Tony WiedHouse · R · WI |
HIMSHims & Hers Health, Inc. · Stock |
Sale $100,001 - $250,000 |
Jan 9, 2026 | Dec 17, 2025 | Filing ↗ |
Lisa C. McClainHouse · R · MI |
HIMSHims & Hers Health, Inc. · Stock |
Purchase $1,001 - $15,000 |
Sep 12, 2025 | Aug 4, 2025 | Filing ↗ |
Tony WiedHouse · R · WI |
HIMSHims & Hers Health, Inc. · Stock |
Purchase $100,001 - $250,000 |
Mar 14, 2025 | Feb 24, 2025 | Filing ↗ |
Tony WiedHouse · R · WI |
HIMSHims & Hers Health, Inc. · Stock |
Purchase $15,001 - $50,000 |
Mar 14, 2025 | Feb 25, 2025 | Filing ↗ |
Whale Activity
Position changes in HIMS reported for 2026-09-30 by 559 institutional filers
- Increased154
- New61
- Held76
- Decreased159
- Closed82
- No prior filing27
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 29.7M | $885.9M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10.4M | $310.1M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.5M | $283.8M | decreased |
| STATE STREET CORP | 8.2M | $245.5M | increased |
| Divisadero Street Capital Management, LP | 7.3M | $218.8M | increased |
| MORGAN STANLEY | 6.2M | $185.9M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 5.6M | $167.8M | decreased |
| UBS Group AG | 4.8M | $141.6M | increased |
| FMR LLC | 4.7M | $139.3M | increased |
| JPMORGAN CHASE & CO | 4.8M | $136.7M | decreased |
| TWO SIGMA INVESTMENTS, LP | 4.4M | $130.2M | new |
| GOLDMAN SACHS GROUP INC | 3.9M | $115.6M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HIMS insiders, by quarter · Form 4
Recent Insider Transactions
1,425 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Okupe OluyemiChief Financial Officer | Sale | −3,518 | $18.53 | $65K | Nov 17, 2026 | Form 4 ↗ |
| Autor Deborah M.Chief Policy Officer · Director | Sale | −23.8K | $18.53 | $442K | Nov 17, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −3,458 | $18.53 | $64K | Nov 17, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −3,462 | $27.60 | $96K | Oct 28, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −3,461 | $29.06 | $101K | Oct 14, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Sale | −2,000 | $29.70 | $59K | Oct 1, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −3,461 | $29.17 | $101K | Sep 30, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Sale | −29.3K | $29.95 | $877K | Sep 22, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Option exercise | +14.0K | $5.01 | $70K | Sep 22, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Sale | −12.3K | $28.82 | $355K | Sep 17, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −6,236 | $27.86 | $174K | Sep 16, 2026 | Form 4 ↗ |
| Elshenawy MohamedCTO | Sale | −7,954 | $28.39 | $226K | Sep 15, 2026 | Form 4 ↗ |
| Chi MichaelChief Operating Officer | Sale | −14.0K | $28.39 | $398K | Sep 15, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −3,458 | $28.33 | $98K | Sep 2, 2026 | Form 4 ↗ |
| Dudum AndrewChief Executive Officer · Director · 10% owner | Other | −977.6K | $0.00 | $0 | Aug 27, 2026 | Form 4 ↗ |
| Dudum AndrewChief Executive Officer · Director · 10% owner | Gift | −463.3K | $0.00 | $0 | Aug 25, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Sale | −4,938 | $29.99 | $148K | Aug 19, 2026 | Form 4 ↗ |
| Okupe OluyemiChief Financial Officer | Option exercise | +4,938 | $5.01 | $25K | Aug 19, 2026 | Form 4 ↗ |
| Boughton SoleilChief Legal Officer | Sale | −25.1K | $27.55 | $692K | Aug 19, 2026 | Form 4 ↗ |
| Autor Deborah M.Chief Policy Officer · Director | Sale | −16.8K | $27.85 | $467K | Aug 18, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HIMS · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 7.3M | $251.4M | 0.20% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 6.7M | $232.8M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 5.5M | $192.3M | 0.23% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 4.9M | $168.6M | 0.09% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2.8M | $97.1M | 0.21% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.4M | $84.4M | 0.09% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 2.0M | $69.2M | 0.45% | Jun 30, 2026 |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 2.0M | $68.5M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 2.4M | $65.6M | 0.19% | Jul 31, 2026 |
| State Street SPDR S&P MidCap 400SM ETF Trust SPDR S&P MIDCAP 400 ETF TRUST | 1.6M | $56.5M | 0.20% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list HIMS's shares (CUSIP 433000106), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Susquehanna Securities, LLCSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
Nov 16, 2026 · ↗ - Susquehanna Investment GroupSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
Nov 16, 2026 · ↗ - SIG Brokerage, LPSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
Nov 16, 2026 · ↗ - G1 Execution Services, LLCSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
Nov 16, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G/A · passive (13G) · 11.2M shares5.0%
Oct 30, 2026 · ↗ - Andrew DudumSCHEDULE 13D/A · activist (13D) · 22.6M shares9.4%
Aug 31, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 11.2M shares5.0%
Jul 31, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 26.5M shares11.9%
Jul 28, 2026 · ↗ - Susquehanna Securities, LLCSCHEDULE 13G · passive (13G) · 14.5M shares6.5%
May 15, 2026 · ↗ - Susquehanna Investment GroupSCHEDULE 13G · passive (13G) · 14.5M shares6.5%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming hims hers health as client
- HIMS & HERS HEALTH, INC.HIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$270K
Filing ↗ - CASSIDY & ASSOCIATES, INC.HIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$40K
Filing ↗ - KOUNTOUPES DENHAM CARR & REID, LLCHIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$60K
Filing ↗ - HIMS & HERS HEALTH, INC.HIMS & HERS HEALTH, INC. · 2026 Q2 · HCR$290K
Filing ↗ - CASSIDY & ASSOCIATES, INC.HIMS & HERS HEALTH, INC. · 2026 Q2 · HCR$50K
Filing ↗
Government Contracts
Federal awards to Hims & Hers Health, Inc. · USAspending
No federal contract awards found for Hims & Hers Health, Inc..
U.S. Patents
Recent USPTO applications naming Hims & Hers Health, Inc.
No USPTO patent applications found for Hims & Hers Health, Inc..
Annual Financials
From HIMS's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M |
| Operating income | $105.6M | $61.9M | -$29.5M | -$68.7M | -$115.0M |
| Net income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M |
| Diluted EPS | $0.51 | $0.53 | -$0.11 | -$0.32 | -$0.58 |
| Operating cash flow | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M |
| Cash and equivalents | $228.6M | $220.6M | $96.7M | $46.8M | $71.8M |
| Total assets | $2.15B | $707.5M | $441.2M | $366.3M | $420.6M |
| Total liabilities | $1.61B | $230.8M | $97.2M | $54.6M | $86.0M |
| Shareholders' equity | $540.9M | $476.7M | $344.0M | $311.7M | $334.6M |
As Hims & Hers Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 23, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in HIMS's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.02Officer / director changeNov 9, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsNov 9, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeOct 7, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 10, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeJul 17, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationJul 1, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 15, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 8.01, 9.01Material agreement · Direct financial obligation · Other eventsJun 2, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 3.02, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityMay 21, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 19, 2026
EDGAR ↗
About Hims & Hers Health, Inc.
From SEC EDGAR company records
Industry (SIC 8011)Services-Offices & Clinics of Doctors of Medicine
SectorHealthcare
HeadquartersSAN FRANCISCO, CA
IncorporatedDE
SEC CIK0001773751 ↗
Former namesOaktree Acquisition Corp.


